Russell Frank Company’s Enzo Biochem, Inc. ENZ Stock Holding History

Russell Frank Company’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$485K	Buy	106,449 +61,368	+136%	+$273K	﹤0.01%	2464
2015 Q4	$207K	Buy	+45,081	New	+$190K	﹤0.01%	2686
2015 Q1	–	Sell	-6,969	Closed	-$31K	–	3059
2014 Q4	$31K	Sell	6,969 -142,549	-95%	-$680K	﹤0.01%	2841
2014 Q3	$770K	Buy	149,518 +6,969	+5%	+$37.2K	﹤0.01%	2192
2014 Q2	$686K	Buy	+142,549	New	+$616K	﹤0.01%	2217
2013 Q4	–	Sell	-19,830	Closed	-$50K	–	3096
2013 Q3	$50K	Hold	19,830	–	–	﹤0.01%	3101
2013 Q2	$41K	Buy	+19,830	New	+$43.8K	﹤0.01%	2904

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

Russell Frank Company's ENZ Position: Q1 2016 in Review

Russell Frank Company increased its Enzo Biochem, Inc. (ENZ) stake by 136% in Q1 2016, buying an estimated $273K and bringing the position to 106,449 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Russell Frank Company first reported a position in ENZ in Q2 2013 and has held it in 7 quarters since. The position peaked at $770K in Q3 2014. 99 funds tracked by Wall St. Rank hold ENZ as of Q1 2016.

Russell Frank Company held 106,449 shares of Enzo Biochem, Inc. worth $485K as of Q1 2016.
Russell Frank Company bought 61,368 Enzo Biochem, Inc. shares in Q1 2016, an estimated $273K.
Enzo Biochem, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2464 holding.
Russell Frank Company first reported a position in Enzo Biochem, Inc. in Q2 2013 and has held it in 7 quarters since.
Russell Frank Company's Enzo Biochem, Inc. position peaked at $770K in Q3 2014.
99 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.